Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Alpha IVF Group BhdXKLS:0303 +1.92%49 Return-on-Tangible-Asset is 21.82% as of May. 2026, which is 1% below its 10-year median of 21.99. GuruFocus rates XKLS:0303 with a GF Score™ of 49/100. The stock has 2 warning signs investors should review. Among 680 Healthcare Providers & Services companies, Alpha IVF Group Bhd ranks better than 95.59% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Alpha IVF Group Bhd's annualizedNet Income for the quarter that ended in May. 2026 was RM55.6 Mil. Alpha IVF Group Bhd's average total tangible assets for the quarter that ended in May. 2026 was RM254.8 Mil. Therefore, Alpha IVF Group Bhd's annualized Return-on-Tangible-Asset for the quarter that ended in May. 2026 was 21.82%.
The historical rank and industry rank for Alpha IVF Group Bhd's Return-on-Tangible-Asset or its related term are showing as below:
XKLS:0303'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -3.89 Med: 21.99 Max: 57.54
Current: 21.55
During the past 7 years, Alpha IVF Group Bhd's highest Return-on-Tangible-Asset was 57.54%. The lowest was -3.89%. And the median was 21.99%.
XKLS:0303's Return-on-Tangible-Asset is ranked better than 95.59% of 680
companies
in the Healthcare Providers & Services industry
Industry Median: 2.465
vs XKLS:0303: 21.55
Alpha IVF Group Bhd (XKLS:0303) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Alpha IVF Group Bhd Return-on-Tangible-Asset Related Terms
Alpha IVF Group Bhd Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for Alpha IVF Group Bhd's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alpha IVF Group Bhd Return-on-Tangible-Asset Chart
XKLS:0303 vs HCA, THC, DVA: Return-on-Tangible-Asset Comparison
For the Medical Care Facilities subindustry, Alpha IVF Group Bhd's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alpha IVF Group Bhd Return-on-Tangible-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Alpha IVF Group Bhd's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Alpha IVF Group Bhd's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (May. 2026) net income data.
What does a Return-on-Tangible-Asset of 21.82% mean?
Alpha IVF Group Bhd (XKLS:0303) has a Return-on-Tangible-Asset of 21.82% as of May. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Alpha IVF Group Bhd and its competitors. This is near median its historical median of 21.99. According to the industry distribution chart, Alpha IVF Group Bhd ranks #30 out of 680 companies in the Healthcare Providers & Services industry, placing it in the top 4.4%.
Is Alpha IVF Group Bhd's Return-on-Tangible-Asset too high?
Alpha IVF Group Bhd's current Return-on-Tangible-Asset of 21.82% is near median its 10-year median of 21.99. The Healthcare Providers & Services industry median Return-on-Tangible-Asset is 2.47. Alpha IVF Group Bhd's value of 21.82% is 785.2% above this industry median. Based on the distribution chart, Alpha IVF Group Bhd ranks #30 out of 680 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Alpha IVF Group Bhd has a GF Score™ of 49/100, reflecting its overall financial health beyond just this single metric.
How does Alpha IVF Group Bhd's Return-on-Tangible-Asset compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Alpha IVF Group Bhd ranks #30 out of 680 companies for Return-on-Tangible-Asset. This places Alpha IVF Group Bhd in the top 4% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Asset is 2.47. Alpha IVF Group Bhd's value of 21.82% is 785.2% above this benchmark. While the company's 10-year median is 21.99 vs. the industry median of 2.47, Alpha IVF Group Bhd has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Healthcare Providers & Services company?
The median Return-on-Tangible-Asset among Healthcare Providers & Services companies is 2.47, based on 680 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alpha IVF Group Bhd's current Return-on-Tangible-Asset of 21.82% is 785.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Alpha IVF Group Bhd and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Asset is 2.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alpha IVF Group Bhd's current Return-on-Tangible-Asset is 21.82%, which is near median its own 10-year median of 21.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alpha IVF Group Bhd stock overvalued right now?
Alpha IVF Group Bhd (XKLS:0303) has a current Return-on-Tangible-Asset of 21.82%. The current Return-on-Tangible-Asset is 21.82%, which is near median its 10-year median of 21.99 and 785.2% above the Healthcare Providers & Services industry median of 2.47. Alpha IVF Group Bhd's overall GF Score™ is 49/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Alpha IVF Group Bhd (XKLS:0303), the current Return-on-Tangible-Asset is 21.82% as of May. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Alpha IVF Group Bhd is a fertility care specialist focusing on assisted reproductive services in Malaysia, Singapore, Indonesia, and China, with the majority of its revenue coming from Malaysia. Assisted reproductive services is a general term that includes all types of fertility treatments and procedures to help people facing difficulties in getting pregnant. The company offers a range of assisted reproductive services such as IVF to assist patients with infertility conditions in achieving clinical pregnancy. It also provides other procedures including intracytoplasmic sperm injection (ICSI), intrauterine insemination (IUI), various diagnostic, testing, and screening procedures, as well as cryopreservation of eggs, sperm, and embryos.
49GF Score
Get the complete analysis for XKLS:0303
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:0303 has been successfully added to your 
